Annual CFF:
$47.66M-$34.74M(-42.16%)Summary
- As of today, TNGX annual cash from financing is $47.66 million, with the most recent change of -$34.74 million (-42.16%) on December 31, 2024.
- During the last 3 years, TNGX annual cash from financing has fallen by -$309.66 million (-86.66%).
- TNGX annual cash from financing is now -86.66% below its all-time high of $357.32 million, reached on December 31, 2021.
Performance
TNGX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$2.54M+$1.96M(+337.35%)Summary
- As of today, TNGX quarterly cash from financing is $2.54 million, with the most recent change of +$1.96 million (+337.35%) on September 30, 2025.
- Over the past year, TNGX quarterly cash from financing has increased by +$139.00 thousand (+5.79%).
- TNGX quarterly cash from financing is now -99.22% below its all-time high of $327.78 million, reached on September 30, 2021.
Performance
TNGX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$4.09M+$139.00K(+3.52%)Summary
- As of today, TNGX TTM cash from financing is $4.09 million, with the most recent change of +$139.00 thousand (+3.52%) on September 30, 2025.
- Over the past year, TNGX TTM cash from financing has dropped by -$44.07 million (-91.50%).
- TNGX TTM cash from financing is now -98.85% below its all-time high of $357.38 million, reached on September 30, 2021.
Performance
TNGX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TNGX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -42.2% | +5.8% | -91.5% |
| 3Y3 Years | -86.7% | +2148.7% | +322.8% |
| 5Y5 Years | -41.1% | -96.9% | -94.9% |
TNGX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -86.7% | +2851.3% | -96.8% | >+9999.0% | -96.8% | +322.8% |
| 5Y | 5-Year | -86.7% | +2851.3% | -99.2% | +440.6% | -98.8% | +322.8% |
| All-Time | All-Time | -86.7% | +2851.3% | -99.2% | +440.6% | -98.8% | +322.8% |
TNGX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $2.54M(+337.3%) | $4.09M(+3.5%) |
| Jun 2025 | - | $581.00K(>+9900.0%) | $3.95M(-15.6%) |
| Mar 2025 | - | $2000.00(-99.8%) | $4.68M(-90.2%) |
| Dec 2024 | $47.66M(-42.2%) | $969.00K(-59.7%) | $47.66M(-1.0%) |
| Sep 2024 | - | $2.40M(+83.2%) | $48.16M(-61.8%) |
| Jun 2024 | - | $1.31M(-96.9%) | $126.04M(+0.6%) |
| Mar 2024 | - | $42.98M(+2829.9%) | $125.31M(+52.1%) |
| Dec 2023 | $82.41M | $1.47M(-98.2%) | $82.41M(+1.2%) |
| Sep 2023 | - | $80.28M(>+9900.0%) | $81.47M(+6171.4%) |
| Jun 2023 | - | $586.00K(+702.7%) | $1.30M(-9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $73.00K(-86.1%) | $1.43M(-11.4%) |
| Dec 2022 | $1.61M(-99.5%) | $527.00K(+366.4%) | $1.61M(+66.8%) |
| Sep 2022 | - | $113.00K(-84.3%) | $968.00K(-99.7%) |
| Jun 2022 | - | $718.00K(+179.4%) | $328.63M(+0.4%) |
| Mar 2022 | - | $257.00K(+314.2%) | $327.17M(-8.4%) |
| Dec 2021 | $357.32M(+341.8%) | -$120.00K(-100.0%) | $357.32M(-0.0%) |
| Sep 2021 | - | $327.78M(>+9900.0%) | $357.38M(+223.4%) |
| Jun 2021 | - | -$746.00K(-102.5%) | $110.52M(-0.7%) |
| Mar 2021 | - | $30.41M(>+9900.0%) | $111.27M(+37.6%) |
| Dec 2020 | $80.88M | -$61.00K(-100.1%) | $80.86M(-0.1%) |
| Sep 2020 | - | $80.92M | $80.92M |
FAQ
- What is Tango Therapeutics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. annual cash from financing year-on-year change?
- What is Tango Therapeutics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. quarterly cash from financing year-on-year change?
- What is Tango Therapeutics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. TTM cash from financing year-on-year change?
What is Tango Therapeutics, Inc. annual cash from financing?
The current annual cash from financing of TNGX is $47.66M
What is the all-time high annual cash from financing for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high annual cash from financing is $357.32M
What is Tango Therapeutics, Inc. annual cash from financing year-on-year change?
Over the past year, TNGX annual cash from financing has changed by -$34.74M (-42.16%)
What is Tango Therapeutics, Inc. quarterly cash from financing?
The current quarterly cash from financing of TNGX is $2.54M
What is the all-time high quarterly cash from financing for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high quarterly cash from financing is $327.78M
What is Tango Therapeutics, Inc. quarterly cash from financing year-on-year change?
Over the past year, TNGX quarterly cash from financing has changed by +$139.00K (+5.79%)
What is Tango Therapeutics, Inc. TTM cash from financing?
The current TTM cash from financing of TNGX is $4.09M
What is the all-time high TTM cash from financing for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high TTM cash from financing is $357.38M
What is Tango Therapeutics, Inc. TTM cash from financing year-on-year change?
Over the past year, TNGX TTM cash from financing has changed by -$44.07M (-91.50%)